JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 273
- -15-5.21%
20min DelayMarket Closed Jul 12 15:00 JST
17.89BMarket Cap-10057P/E (Static)
287High270Low2.85MVolume284Open288Pre Close788.24MTurnover34052wk High50.56%Turnover Ratio65.54MShares14252wk Low-27.143EPS TTM1.54BFloat Cap340Historical HighLossP/E (Static)5.64MShs Float142Historical Low-27.143EPS LYR5.90%Amplitude--Dividend TTM3.56P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
Address2-26-1 Muraoka-Higashi Kanagawa
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --
- Yukari Nishikata
- Independent Director
- --
- Kousuke Ishii
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg